Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

MediWound (MDWD) Other Operating Expenses (2016 - 2025)

MediWound has reported Other Operating Expenses over the past 13 years, most recently at -$17000.0 for Q4 2025.

  • For Q4 2025, Other Operating Expenses fell 194.44% year-over-year to -$17000.0; the TTM value through Dec 2025 reached $1.4 million, down 37.31%, while the annual FY2025 figure was -$13000.0, 172.22% down from the prior year.
  • Other Operating Expenses for Q4 2025 was -$17000.0 at MediWound, down from $1.5 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $1.5 million in Q2 2025 and troughed at -$224000.0 in Q3 2023.
  • A 5-year average of $695230.8 and a median of $854000.0 in 2021 define the central range for Other Operating Expenses.
  • Biggest five-year swings in Other Operating Expenses: surged 574.55% in 2024 and later tumbled 194.44% in 2025.
  • Year by year, Other Operating Expenses stood at $872000.0 in 2021, then plummeted by 57.0% to $375000.0 in 2022, then crashed by 96.53% to $13000.0 in 2023, then surged by 38.46% to $18000.0 in 2024, then plummeted by 194.44% to -$17000.0 in 2025.
  • Business Quant data shows Other Operating Expenses for MDWD at -$17000.0 in Q4 2025, $1.5 million in Q2 2025, and $18000.0 in Q4 2024.